OBJECTIVES: To determine (a) the respondents' perceptions of 4 unclear or conflicting cancer screening guidelines: prostate-specific antigen (PSA) for men over 50, mammography for women 40-49, colorectal screening by fecal occult blood testing (FOBT), and colonoscopy for patients over 40; and (b) the influence of various factors on the decision to order these tests. STUDY DESIGN: National Canadian mail survey of randomly selected family physicians. POPULATION: Family physicians in active practice (n=565) selected from rural and urban family medicine sites in 5 provinces representing the main regions in Canada. OUTCOME MEASURED: Agreement with guideline statements, and decision to order screening test in 6 clinical vignettes. RESULTS: Of 565 surveys mailed, 351 (62.1%) were returned. Most respondents agreed with the Canadian Task Force recommendations, and most believed that various guidelines for 3 of the 4 screens were conflicting (PSA 86.6%; mammography 67.5%; FOBT 62.4%). Patient anxiety about cancer, patient expectations of being tested, and a positive family history of cancer increased the odds that the 4 tests would be ordered. A good quality patient-MD relationship decreased the odds of ordering a mammogram. Screening decisions were also significantly influenced by the respondents' beliefs about whether screening was recommended and whether screening could cause more harm than good. A physician's sensitivity to his or her colleagues' practice influenced screening decisions regarding PSA and mammography. CONCLUSIONS: These results suggest a conceptual framework for understanding the determinants of screening behavior when guidelines are unclear or conflicting.
OBJECTIVES: To determine (a) the respondents' perceptions of 4 unclear or conflicting cancer screening guidelines: prostate-specific antigen (PSA) for men over 50, mammography for women 40-49, colorectal screening by fecal occult blood testing (FOBT), and colonoscopy for patients over 40; and (b) the influence of various factors on the decision to order these tests. STUDY DESIGN: National Canadian mail survey of randomly selected family physicians. POPULATION: Family physicians in active practice (n=565) selected from rural and urban family medicine sites in 5 provinces representing the main regions in Canada. OUTCOME MEASURED: Agreement with guideline statements, and decision to order screening test in 6 clinical vignettes. RESULTS: Of 565 surveys mailed, 351 (62.1%) were returned. Most respondents agreed with the Canadian Task Force recommendations, and most believed that various guidelines for 3 of the 4 screens were conflicting (PSA 86.6%; mammography 67.5%; FOBT 62.4%). Patientanxiety about cancer, patient expectations of being tested, and a positive family history of cancer increased the odds that the 4 tests would be ordered. A good quality patient-MD relationship decreased the odds of ordering a mammogram. Screening decisions were also significantly influenced by the respondents' beliefs about whether screening was recommended and whether screening could cause more harm than good. A physician's sensitivity to his or her colleagues' practice influenced screening decisions regarding PSA and mammography. CONCLUSIONS: These results suggest a conceptual framework for understanding the determinants of screening behavior when guidelines are unclear or conflicting.
Authors: Susan A Sabatino; Risa B Burns; Roger B Davis; Russell S Phillips; Ellen P McCarthy Journal: J Gen Intern Med Date: 2006-04 Impact factor: 5.128
Authors: Alan Katz; Anita Lambert-Lanning; Anthony Miller; Barbara Kaminsky; Jennifer Enns Journal: Can Fam Physician Date: 2012-01 Impact factor: 3.275
Authors: Paul K J Han; Carrie N Klabunde; Nancy Breen; Gigi Yuan; Alyssa Grauman; William W Davis; Stephen H Taplin Journal: Med Care Date: 2011-02 Impact factor: 2.983
Authors: Samir Gupta; Navjot Rai; Onil Bhattacharrya; Alice Y Y Cheng; Kim A Connelly; Louis-Philippe Boulet; Alan Kaplan; Melissa C Brouwers; Monika Kastner Journal: CMAJ Date: 2016-04-18 Impact factor: 8.262
Authors: Maria Ramos; Magdalena Esteva; Jesús Almeda; Elena Cabeza; Diana Puente; Rosa Saladich; Albert Boada; Maria Llagostera Journal: BMC Cancer Date: 2010-09-20 Impact factor: 4.430
Authors: Alison J Huang; Eliseo J Pérez-Stable; Sue E Kim; Sabrina T Wong; Celia P Kaplan; Judith M E Walsh; A Yuri Iwaoka-Scott; George F Sawaya Journal: J Gen Intern Med Date: 2008-05-28 Impact factor: 5.128